Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANT-1401 for Crow's Feet
NCT01951742Phase 2Completed
- Sponsor
- Anterios, Inc.
- Start
- Sep 2013
- Primary completion
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ANT-1401 in lateral canthal rhytides (6 arms), sponsored by Anterios, Inc. Primary endpoint: Investigators Global Assessment at 4 weeks. Started Sep 2013; status: completed.
02
Drugs
ANT-1401
03
Conditions
lateral canthal rhytides
Beyond the preview
Go deeper on NCT01951742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01951742.